South Africa's public health sector struggling with shortages of 80 drugs

17 May 2010

South Africa is experiencing a shortage of over 80 different drugs in its public health sector, including flu vaccinations and medication for tuberculosis and high blood pressure, reports the Inter Press Service (IPS) news agency. The severity of shortages varies from province to province and hospital to hospital, depending on the leadership and skills levels of management.

Experts blame the shortage on a number of factors, including a lack of trained pharmacists, an ineffective tendering process and the inability of some pharmaceutical companies to deliver drugs.

South Africa has about 9,000 working pharmacists, although 10,824 names appear on the register of pharmaceutical practitioners, according to Andy Gray, a senior lecturer in therapeutics and medicines management at the University of KwaZulu-Natal. Only 1,746 are working in the public sector, the IPS noted.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical